Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina

Published:2011-07-11 Issue:8 Volume:28 Page:640-649
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Eizenberg Peter,Booy Robert,Naser Nadim,Mason Glen,Stamboulian Daniel,Weber Françoise

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s12325-011-0042-0

Reference14 articles.

1. Tosh PK, Jacobson RM, Poland GA. Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc. 2010;85:257–273.

2. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142:85–89.

3. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009;58:446–458.

4. Prausnitz MR, Mikszta JA, Cormier M, et al. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009;333:369–393.

5. Laurent PE, Bonnet S, Alchas P, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine. 2007;25:8833–8842.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination: Towards an Improved Influenza Vaccine;Principles of Biomedical Sciences and Industry;2022-07-22

2. Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses;Pharmaceutical Development and Technology;2021-12-08

3. Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines;JAMA Network Open;2021-02-09

4. Intradermal versus Intramuscular Administration of Influenza Vaccination: Rapid Review and Meta-analysis;2020-10-08

5. Human studies with microneedles for evaluation of their efficacy and safety;Expert Opinion on Drug Delivery;2017-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3